Clinical trials
Recruiting Phase 1/2 Pancreatic Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
82 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 2 |
| 2020 | 2 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 8 |
| 2024 | 18 |
| 2025 | 18 |
| 2026 | 17 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 82 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 5 |
| Beijing Biotech | 3 |
| Revolution Medicines, Inc. | 3 |
| Cancer Research UK | 2 |
| Essen Biotech | 2 |
| Jacobio Pharmaceuticals Co., Ltd. | 2 |
| A2 Biotherapeutics Inc. | 1 |
| Anova Innovation Limited | 1 |
| Ascentawits Pharmaceuticals, Ltd | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pancreatic Neoplasms | 82 |
| Colorectal Neoplasms | 26 |
| Carcinoma, Non-Small-Cell Lung | 20 |
| Lung Neoplasms | 17 |
| Neoplasm Metastasis | 17 |
| Ovarian Neoplasms | 17 |
| Stomach Neoplasms | 17 |
| Prostatic Neoplasms | 13 |
| Breast Neoplasms | 12 |
| Esophageal Neoplasms | 12 |
Trials
Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.